ACE2 and COVID-19: Therefore, ACE2 depletion caused by COVID-19 may become a risk factor for impaired placental vascularization, maternal blood pressure elevation and adverse pregnancy outcomes associated with placental dysfunction and also aggravate pre-existing conditions in pregnant women.